Document is current
Any future updates will be listed below
-
Authors
Steinke, Jonathan https://orcid.org/0009-0004-2332-7169
Di Cristanziano, Veronica https://orcid.org/0000-0003-1604-8386
Naendrup, Jan-Hendrik https://orcid.org/0000-0002-6420-7938
Cadar, Dániel https://orcid.org/0000-0002-8063-2766
Gabriel, Martin
Grosser, Roger
Sieg, Noëlle
Altenrath, Lisa
Welters, Jesko
Simonis, Alexander https://orcid.org/0000-0003-2945-9897
Sprute, Rosanne https://orcid.org/0000-0003-2457-6437
Garcia Borrega, Jorge https://orcid.org/0000-0003-1326-1560
Steger, Gertrud https://orcid.org/0000-0002-0581-8122
Schmidt-Chanasit, Jonas https://orcid.org/0000-0003-4433-0231
Shimabukuro-Vornhagen, Alexander https://orcid.org/0000-0002-2351-7294
Gruell, Henning https://orcid.org/0000-0002-0725-7138
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 6 October 2024
Accepted: 12 December 2024
First Online: 28 December 2024
Declarations
:
: Informed consent for publication of case details was obtained from the patient’s next of kin.
: J.-H.N. and N.S. received unrelated funding from the Else Kröner-Fresenius-Stiftung. R.S. received speaker fees from Akademie für Infektionsmedizin e.V., Hikma, and Pfizer, as well as travel support from Pfizer; all unrelated to this work. J.G.B. received unrelated research funding and travel support from Kite/Gilead. J.S.-C. reports potential conflicts of interest from employment, participation, consulting activities, or donations for research projects, lectures, or other activities from AstraZeneca, BASF, Bavarian Nordic, Blusense Diagnostics, Diasorin, EUROIMMUN (a PerkinElmer company), Hermes Arzneimittel, Johnson & Johnson, Mikrogen, Pfizer, Roche, Sanofi, Siemens, Sonic Healthcare, Takeda, and Valneva. The remaining authors report no conflicts of interest.
